Giles, F., Mahon, F., Gjertsen, B., Swords, R., Labar, B., Turkina, A., & Rosti, G. (2012). Developmental Therapeutics Consortium report on study design effects on trial outcomes in chronic myeloid leukaemia. European Journal of Clinical Investigation, 42(9), 1016. https://doi.org/10.1111/j.1365-2362.2012.02675.x
Chicago Style (17th ed.) CitationGiles, Francis, François-Xavier Mahon, Bjorn Gjertsen, Ronan Swords, Boris Labar, Anna Turkina, and Gianantonio Rosti. "Developmental Therapeutics Consortium Report on Study Design Effects on Trial Outcomes in Chronic Myeloid Leukaemia." European Journal of Clinical Investigation 42, no. 9 (2012): 1016. https://doi.org/10.1111/j.1365-2362.2012.02675.x.
MLA (9th ed.) CitationGiles, Francis, et al. "Developmental Therapeutics Consortium Report on Study Design Effects on Trial Outcomes in Chronic Myeloid Leukaemia." European Journal of Clinical Investigation, vol. 42, no. 9, 2012, p. 1016, https://doi.org/10.1111/j.1365-2362.2012.02675.x.